SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-22-014325
Filing Date
2022-05-18
Accepted
2022-05-18 16:24:55
Documents
12
Period of Report
2022-05-03
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 54016
  Complete submission text file 0001493152-22-014325.txt   234531

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE envb-20220503.xsd EX-101.SCH 2956
3 XBRL LABEL FILE envb-20220503_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE envb-20220503_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 4286
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38286 | Film No.: 22939425
SIC: 2834 Pharmaceutical Preparations